New peptides for cardiovascular research : Kinins

Products & Services

We expand our catalog of peptides for cardiovascular research with Bradykinin (BK) and related kinin peptides.

AnaSpec is pleased to offer an expanded catalog of kinin peptides including the B1 & B2 type receptor agonists/antagonists relevant in the context of drug research and development in inflammatory pathologies governing cardiovascular physiology. 

Bradykinins and their receptors play active roles in contributing towards lowering blood pressure, influencing pathways in cancers and neurological pathologies, and acting as therapeutic targets in cardiovascular disease.

View our Collection

Trending Now

New labeled albumins for detection studies

Next post

Recommended for you

Cyclic Peptides: Structure, Uses, and Advan..

Products & Services

Cyclic peptides are reshaping drug development and research, offering unique advantages over their linear counterparts....
Continue Reading

Chelating Peptides for Radiopharmaceuticals..

Products & Services

Peptide-based radiopharmaceutical therapy (RPT), using chelating peptides to deliver radioisotopes directly to tumor sites, is...
Continue Reading

Annual Closing 2025

Company

Anaspec will be closed from Wednesday, December 24, 2025, through Friday, January 2, 2026....
Continue Reading